April 4, 2019
Torrent Pharmaceuticals (Torrent) announced on March 1, 2019, that it’s issuing a nationwide, voluntary recall on 60 lots of Losartan potassium tablets USP and 54 lots of Losartan potassium/hydrochlorothiazide tablets. Torrent issued the recall due to detection of trace amounts of an impurity, N-nitrosodimethylamine (NDEA), which is classified as a human carcinogen.
Because Losartan treats serious medical conditions, we’re advising our customers to continue taking their prescription and to contact their provider for further instruction.
You don’t need to write a new prescription if you opt to switch your patient to a different manufacturer.
Learn more about the recalled products including product names, catalog numbers, lot numbers, and expiration dates. For questions about potential impacts to your Premera patients, call your provider network representative at 877-342-5258, option 4.